Biotechnology - UK, GlaxoSmithKline

Filter

Current filters:

UKGlaxoSmithKline

Popular Filters

Adaptimmune completes $104 million round of financing to advance cancer therapies

Adaptimmune completes $104 million round of financing to advance cancer therapies

25-09-2014

Adaptimmune, a UK biotech company focused on using T-cell therapy to treat cancer and infectious disease,…

AdaptimmuneBiotechnologyFinancialGlaxoSmithKlineOncologyUK

COMPANY SPOTLIGHT

Menarini

Back to top